DNA-RNA Extraction Market to Reach USD 3.42 Billion by 2036 at a CAGR of 7.1% | Driven by Genomics and Automation Demand
The DNA-RNA Extraction Market Growth is being driven by rapid expansion in clinical genomics, liquid biopsy adoption, and increasing automation across molecular diagnostics laboratories.
NEWARK, DE / ACCESS Newswire / April 30, 2026 / According to latest insights by Future Market Insights, global DNA-RNA extraction market is projected to grow from USD 1.72 billion to USD 3.42 billion by 2036, expanding at a CAGR of 7.1% during the forecast period. The DNA/RNA extraction market is undergoing a structural shift from manual, protocol-driven laboratory workflows to standardized, automation-ready systems designed for clinical throughput. As genomic sequencing expands across oncology, infectious disease testing, and pharmacogenomics, nucleic acid extraction is no longer a preparatory step it is a critical control point for diagnostic accuracy, regulatory compliance, and operational efficiency.
Driven by precision medicine programs and high-throughput laboratory requirements, the market is evolving into a platform-centric ecosystem where integration, reproducibility, and automation compatibility define competitive advantage.
Quick Stats Snapshot
Market size (2026): USD 1.72 billion
Forecast (2036): USD 3.42 billion
CAGR (2026-2036): 7.1%
Top product segment: Kits & reagents - 61% share
Leading method: Column-based - 43% share
Dominant sample type: Blood - 50% share
Fastest-growing market: South Korea (7.4% CAGR)
Get Detailed Market Forecasts, Competitive Benchmarking, and Pricing Trends: https://www.futuremarketinsights.com/reports/sample/rep-gb-10543
Market Size and Growth Outlook
The DNA/RNA extraction market is projected to nearly double from USD 1.72 billion in 2026 to USD 3.42 billion by 2036, growing at a CAGR of 7.1%. This growth reflects the rapid expansion of molecular diagnostics and genomic research, particularly in clinical settings where standardized workflows are essential. Unlike earlier phases of growth driven by research demand, the current trajectory is increasingly shaped by clinical adoption, where scalability, validation, and regulatory compliance are paramount.
Growth Drivers: Clinical Genomics, Liquid Biopsy, and Automation
Expansion of Clinical Sequencing
Hospitals and diagnostic centers are expanding test menus to include:
Oncology profiling
Infectious disease sequencing
Pharmacogenomics
Each new test increases recurring demand for high-quality extraction kits.
Rise of Liquid Biopsy
Non-invasive diagnostics are driving demand for extraction technologies capable of isolating cell-free DNA and RNA from blood samples requiring higher sensitivity and precision.
Automation of Laboratory Workflows
High-throughput laboratories are transitioning toward:
Magnetic bead-based and column-based automated systems
Robotic liquid handling platforms
Integrated extraction-to-analysis workflows
Automation is now a primary procurement criterion.
Market Challenges: Cost and Infrastructure Barriers
High capital costs for automated extraction platforms
Laboratory space constraints, particularly in smaller facilities
Regulatory requirements for validated protocols in clinical diagnostics
These factors sustain demand for manual and semi-automated solutions in cost-sensitive environments.
Opportunities: Platform Integration and Emerging Applications
Integrated Workflow Solutions
Manufacturers offering end-to-end systems from extraction to sequencing are gaining traction, particularly in clinical settings.
Expansion in Drug Discovery and Biotech
Pharmaceutical and biotech companies are increasing demand for:
Biomarker research
Clinical trial analysis
Cell and gene therapy development
Sample Type Diversification
While blood dominates, growing use of saliva and tissue samples is expanding application scope, particularly in consumer genomics and pathology.
Segmentation Insights: Standardization Drives Market Structure
By Product Type: Kits & Reagents Lead
Accounting for 61% of the market, kits and reagents dominate due to:
Ease of use and standardization
Reduced protocol variability
Compatibility with automated systems
By Method: Column-Based Remains Strong
Column-based extraction holds 43% share, supported by:
Established laboratory workflows
Reliable and reproducible yields
Magnetic bead-based methods are gaining share due to automation compatibility.
By End User: Hospitals and Diagnostic Centers
With 42% share, hospitals lead demand, reflecting the rapid expansion of molecular diagnostics and clinical genomics.
Speak to Analyst: Customize insights for your business strategy: https://www.futuremarketinsights.com/customization-available/rep-gb-10543
Regional Analysis: Asia and North America Drive Growth
South Korea: Leading Growth Market
With a 7.4% CAGR, South Korea benefits from:
Government investment in precision medicine
Expansion of clinical genomics infrastructure
Growth in biotechnology research
United States: Clinical and Research Powerhouse
At 7.3% CAGR, the U.S. market is driven by:
Large-scale biobanking initiatives
NIH-funded genomic research
Expansion of companion diagnostics
Europe: Regulation-Driven Demand
The European Union's 7.0% CAGR reflects:
Compliance with IVDR regulations
Strong research funding programs
Increasing clinical genomics adoption
UK and Japan: Steady Expansion
Both markets show consistent growth supported by national genomics initiatives and laboratory automation investments.
Competitive Landscape: Platform Integration and Regulatory Strength Define Leaders
The market is moderately consolidated, with leading players focusing on automation, integration, and regulatory compliance:
Qiagen N.V. leads with ~22% share, driven by a broad portfolio and strong automation platform presence
Thermo Fisher Scientific Inc. competes through integrated workflows spanning extraction to sequencing
Roche Diagnostics leverages clinical diagnostics platforms for market penetration
Promega Corporation focuses on specialized extraction chemistries
Bio-Rad Laboratories Inc. maintains strength in research-focused applications
Emerging players such as Zymo Research Corporation and Macherey-Nagel are expanding through cost-competitive and niche solutions.
Strategic Implications for Industry Stakeholders
Automation compatibility is now a core purchasing criterion
Regulatory compliance (IVD clearance) is critical for clinical adoption
Integrated platform offerings provide competitive advantage
Recurring revenue models from consumables (kits) are central to profitability
Unlock 360° insights for strategic decision making and investment planning - https://www.futuremarketinsights.com/checkout/10543
Future Outlook: Toward Standardized, High-Throughput Genomics Infrastructure
The DNA/RNA extraction market is expected to evolve along three key dimensions:
Automation-first laboratory environments, reducing manual intervention
Integration with sequencing and diagnostic platforms, enabling seamless workflows
Specialized extraction solutions for emerging applications like liquid biopsy
As precision medicine scales globally, extraction technologies will remain foundational to diagnostic accuracy and research innovation.
Executive Takeaways
The market will grow at 7.1% CAGR through 2036, driven by clinical genomics expansion
Kits & reagents dominate, reflecting demand for standardized, ready-to-use solutions
Hospitals and diagnostic centers are the primary growth engines
Asia (South Korea) and the U.S. lead global expansion
Competitive success depends on automation, integration, and regulatory compliance
Related Reports:
Kidney Stone Extraction Balloon Market: https://www.futuremarketinsights.com/reports/kidney-stone-extraction-balloon-market
Nucleic Acid Extraction Kit Market: https://www.futuremarketinsights.com/reports/nucleic-acid-extraction-kit-market
Plant Genome Extraction Kit Market: https://www.futuremarketinsights.com/reports/plant-genome-extraction-kit-market
Viral RNA Extraction Kit Market: https://www.futuremarketinsights.com/reports/viral-rna-extraction-kit-market
Extraction Kits Market: https://www.futuremarketinsights.com/reports/extraction-kits-market
About Future Market Insights (FMI)
Future Market Insights (FMI) delivers actionable, decision-maker-focused research backed by real industry inputs and robust forecasting models. The company specializes in:
Pricing analysis and cost benchmarking
Supply chain and procurement intelligence
Technology adoption insights across nutraceuticals and functional ingredients
Customized research for strategic decision-making
FMI combines bottom-up research with expert validation to provide practical, business-ready insights that help companies optimize investments and stay competitive in rapidly evolving markets.
For Press & Corporate Inquiries
Rahul Singh
AVP - Marketing and Growth Strategy
Future Market Insights, Inc.
+91 8600020075
For Sales - [email protected]
For Media - [email protected]
For web - https://www.futuremarketinsights.com/
SOURCE: Future Market Insights, Inc.